RACHEL LYNCH: Open Payments
NPI 1740952902 · LINESVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 15 payments from 10 companies in 2025. Trend: 2023 $146 · 2024 $308 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| Exact Sciences Corporation | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Amgen Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| PFIZER INC. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Verona Pharma, Inc. | 1 | $18 |
| Abbott Laboratories | 1 | $14 |
Products named: XIFAXAN, Wegovy, Cologuard Collection Kit, Auvelity, EVENITY, VERQUVO, Ozempic, PAXLOVID.
Industry payments across PA — which companies pay providers there.
